Conservest Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,998
Closed -$264K 115
2024
Q3
$264K Hold
1,998
0.03% 92
2024
Q2
$264K Hold
1,998
0.03% 91
2024
Q1
$264K Buy
1,998
+2
+0.1% +$247 0.03% 92
2023
Q4
$218K Buy
1,996
+3
+0.2% +$311 0.02% 99
2023
Q3
$205K Sell
1,993
-148
-7% -$16K 0.02% 96
2023
Q2
$247K Buy
+2,141
New +$243K 0.03% 88
2023
Q1
Sell
-2,025
Closed -$225K 102
2022
Q4
$225K Buy
+2,025
New +$207K 0.03% 82
2020
Q4
Sell
-2,528
Closed -$200K 79
2020
Q3
$200K Buy
+2,528
New +$198K 0.03% 74
2020
Q2
Sell
-2,781
Closed -$204K 73
2020
Q1
$204K Buy
2,781
+6
+0.2% +$472 0.03% 67
2019
Q4
$241K Buy
2,775
+7
+0.3% +$575 0.03% 75
2019
Q3
$222K Sell
2,768
-565
-17% -$45.3K 0.03% 77
2019
Q2
$267K Sell
3,333
-122
-4% -$9.34K 0.04% 71
2019
Q1
$274K Sell
3,455
-312
-8% -$23.3K 0.04% 71
2018
Q4
$275K Sell
3,767
-1,951
-34% -$138K 0.05% 67
2018
Q3
$387K Buy
5,718
+7
+0.1% +$446 0.06% 60
2018
Q2
$331K Sell
5,711
-1,072
-16% -$60.5K 0.05% 67
2018
Q1
$353K Sell
6,783
-2,686
-28% -$145K 0.08% 57
2017
Q4
$508K Buy
9,469
+75
+0.8% +$4.16K 0.1% 51
2017
Q3
$574K Sell
9,394
-156
-2% -$9.46K 0.09% 56
2017
Q2
$584K Sell
9,550
-136
-1% -$8.28K 0.12% 42
2017
Q1
$587K Buy
+9,686
New +$588K 0.12% 42

Other funds holding MRK

Conservest Capital Advisors's MRK Position: Q4 2024 in Review

Conservest Capital Advisors sold out of Merck (MRK) in Q4 2024, closing a stake of 1,998 shares — an estimated $264K sold.

Conservest Capital Advisors first reported a position in MRK in Q1 2017 and held it in 21 quarters. The position peaked at $587K in Q1 2017. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Conservest Capital Advisors reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Conservest Capital Advisors sold 1,998 Merck shares in Q4 2024, an estimated $264K.
  • Conservest Capital Advisors first reported a position in Merck in Q1 2017 and held it in 21 quarters.
  • Conservest Capital Advisors's Merck position peaked at $587K in Q1 2017.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Conservest Capital Advisors's 13F filing for Q4 2024, filed 5 Feb 2025.